Irwin Naturals Acquires Third Ketamine Clinic, Steps Further Into New England Region
[ad_1] Plant-based medicine producer Irwin Naturals Inc. IWINF has purchased all the assets of New England Ketamine located in Salem, New Hampshire and serving patients in six states in the…
Psychedelics And The National Institutes Of Health—How Do They Relate?
[ad_1] As David Hodes first noted in The Green Market Report, the U.S. National Institutes of Health (NIH)’s growing interest in psychedelic studies is remarkable. The agency annually invests about $41.7…
Congress: Two New Bills Would Pressure The DEA To Allow Patient Access To Psychedelics And Marijuana
[ad_1] On July 20, bipartisan lawmakers from both chambers of Congress sent companion bills clarifying that federal Right to Try (RTT) laws give terminally-ill patients access to Schedule I substances including marijuana and…
Michael Pollan On The Late Show With Stephen Colbert: Past, Present And Future Of Psychedelics
[ad_1] Best-selling journalist and author Michael Pollan appeared live at The Late Show with Stephen Colbert on Thursday, on the heels of the Netflix release of How To Change Your Mind. “I…
Awakn’s Phase 3 Trial On Ketamine Therapy Gets Almost $2M From UK State Funding
[ad_1] Biotech psychedelics company Awakn Life Sciences Corp. AWKNF has been granted funding for 66% of the costs from its phase 3 clinical trial on ketamine therapy for alcohol use disorder…